Comphya

medical devices

About

Comphya is a clinical-stage medical device company based in Lausanne, Switzerland, dedicated to developing innovative treatments for erectile dysfunction (ED). The company is focused on CaverSTIM, the first implantable neurostimulation device designed to restore natural erectile function through neuromodulation of the cavernous nerve. This device provides a less invasive alternative to traditional treatments, such as intrapenile injections and penile implants. Comphya's technology allows for self-controlled stimulation via a wireless remote, offering a safer and more comfortable solution for men with ED, particularly those who do not respond to oral medications. The company has successfully raised CHF 7.5 million to support its clinical programs in the U.S. and Australia, and it has received FDA Investigational Device Exemption approval to begin a pilot clinical study. Comphya aims to address a significant unmet medical need and improve the quality of life for men affected by ED, including those with conditions resulting from prostate cancer treatment or spinal cord injuries.

Technologies

Gmail Google Apps DigitalOcean Nginx Mobile Friendly Shutterstock WordPress.org Android Circle Remote Deel AI Databricks Data Storage

Keywords

urology medical devices neuroprosthetics erectile dysfunction neuroprosthetic system implantable neurostimulator medical equipment and supplies manufacturing wireless remote control implantable device ed treatment neurostimulation wireless recharger pelvic nerve stimulation neuromodulation medical device neurostimulator patient safety spinal cord injury ed b2c clinical validation neurostimulation system electrode paddle post-prostatectomy ed clinical trial implant surgery regulatory approval neuromodulation therapy patient-controlled stimulation healthcare neuroscience

Location

Route Cantonale, Ecublens, Vaud, Switzerland, 1015

Related Companies

Companies in the same industry